JCRB4004 KE-43C4

Cell information

Important Notice(s)

JCRB4004 KE-43C4 notes for cultivation / 培養上の注意

Cell type:general cells (View Pricing Information)

JCRB No.   JCRB4004 Cell Name   KE-43C4
Profile   Well-differentiated adenocarcinoma obtained by cloning KE-43 Other Name   
Animal   human Strain   
Genus   Homo Species   sapiens
Sex   F Age   54-year-old
Identity   available Tissue for Primary Cancer   colon
Case history    Metastasis   
Tissue Metastasized    Genetics   
Life Span    Crisis PDL   
Morphology   epithelial-like Character   DT=63.6 hrs
Classify   tumor Established by   Kazuya YAMASHITA
Registered by   YAMASHITA Kazuya Regulation for Distribution   
Comment    Year   
Medium   MEM+10%FBS Methods for Passages   0.25%Trypsin+0.02%EDTA, passage 1:10split /1 week
Cell Number on Passage    Race   
CO2 Conc.   5% Tissue Sampling   primary colonic carcinoma
Tissue Type   

Detection of virus genome fragment by Real-time PCR
Detected DNA Virus tested Detected RNA Virus not tested
CMV - parvoB19 - -/negative.
+/positive.
nt/not tested.
(positive (+) does not immediately mean the production of infectious viral particles.)
EBV - HBV -
HHV6 - HTLV-1 -
HHV7 - HTLV-2 -
BKV - HIV-1 -
JCV - HIV-2 -
ADV - HPV18 -
Notes

Reference
Pubmed id:16206288Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
Yoshida T,Haga S,Numata Y,Yamashita K,Mikami T,Ogawa T,Ohkusa T,Okayasu I
Int J Cancer. 2006 Mar 15;118(6):1395-403
Pubmed id:15016319Unique characteristics of rectal carcinoma cell lines derived from invasive carcinomas in ulcerative colitis patients.
Yamashita K,Yasuda S,Kuba T,Otani Y,Fujiwara M,Okayasu I
Cancer Sci. 2004 Mar;95(3):211-7
Pubmed id:1390419[Establishment and characterization of a human colonic cancer cell line expressing carbohydrate antigen 19-9 and carcinoembryonic antigen].
Atari E,Watanabe K,Yamashita K
Hum Cell. 1992 Jun;5(2):174-9
Pubmed id:none細胞株を用いた免疫組織化学染色マルチプルコントロール試料の作製と標準化の基礎的検討.
山下和也, 他.
神奈川県臨床検査技師会雑誌(2188-6628)
Pubmed id:noneヒト大腸癌培養細胞株の腹腔内増殖能と癌関連遺伝子および癌関連蛋白異常に関する検討.
西山保比古、他.
日本大腸肛門病学会雑誌、50: 562- 571, 1997.




LOT Information

Cell No.   JCRB4004 Cell Name   KE-43C4
LOT No.   03112024 Lot Specification   distribution
Medium   Dulbecco's modified Eagle's medium (GIBCO:catalog No.11885-084) with 10% heat inactivated fetal bovine serum (SIGMA, Cat#172012, Lot#12J396). Temperature   37 C
Cell Density at Seeding   0.36-1.6x10^4 cells/sq.cm Methods for Passages   Cells were harvested after treatment with 0.25% trypsin (GIBCO) and 0.02% EDTA. (1/10 split/week)
Doubling Time   NT Cell Number in Vial (cells/1ml)   2.8x10^6
Viability at cell freezing (%)   97.90 Antibiotics Used   free
Passage Number   p7* PDL   NT
Sterility: MYCOPLASMA   - Sterility: BACTERIA   -
Sterility: FUNGI   - Isozyme Analysis   
Chromosome Mode   NT Chromosome Information   NT
Surface Antigen   NT DNA Profile (STR)   D5S818:10,12
D13S317:9
D7S820:8,10
D16S539:9,11
VWA:14,18
TH01:6
AM:X
TPOX:8
CSF1PO:11,12
Adhesion   Yes Exoteric Gene   NT
Medium for Freezing   BAMBANKER (LYMPHOTEC Inc., CS-02-001, NIPPON Genetics Co., LTD) CO2 Conc.   5%
Viability immediately after thawing (%)   95.5 Additional information   We recommend to start culture with 25T flask.
CLOSE